MX2021010908A - Metodo para tratar y/o prevenir asma, exacerbaciones de asma, asma alergica y/o condiciones asociadas con microbiota relacionada con trastornos respiratorios. - Google Patents

Metodo para tratar y/o prevenir asma, exacerbaciones de asma, asma alergica y/o condiciones asociadas con microbiota relacionada con trastornos respiratorios.

Info

Publication number
MX2021010908A
MX2021010908A MX2021010908A MX2021010908A MX2021010908A MX 2021010908 A MX2021010908 A MX 2021010908A MX 2021010908 A MX2021010908 A MX 2021010908A MX 2021010908 A MX2021010908 A MX 2021010908A MX 2021010908 A MX2021010908 A MX 2021010908A
Authority
MX
Mexico
Prior art keywords
asthma
treating
respiratory disorders
preventing
obtainable
Prior art date
Application number
MX2021010908A
Other languages
English (en)
Inventor
Jacques Bauer
Donata Vercelli
Christian Pasquali
Vadim Pivniouk
Fernando Martinez
Original Assignee
Om Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2019107206A external-priority patent/RU2800051C2/ru
Application filed by Om Pharma Sa filed Critical Om Pharma Sa
Publication of MX2021010908A publication Critical patent/MX2021010908A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a métodos novedosos y rutas de administración de extractos bacterianos específicos que se pueden obtener por lisis alcalina de especies bacterianas Gram positivas o Gram negativas y dispositivos de administración para tratar y/o prevenir síntomas asociados con asma, exacerbación de asma, condiciones de asma alérgica y/o sibilancia y/o asociados con microbiota relacionada con trastornos respiratorios en un sujeto en necesidad de lo mismo que comprenden administrar una cantidad terapéuticamente efectiva de extracto bacteriano que se puede obtener de especies bacterianas Gram positivas o Gram negativas en donde este extracto bacteriano se puede obtener por lisis alcalina.
MX2021010908A 2019-03-14 2019-09-13 Metodo para tratar y/o prevenir asma, exacerbaciones de asma, asma alergica y/o condiciones asociadas con microbiota relacionada con trastornos respiratorios. MX2021010908A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19162717 2019-03-14
RU2019107206A RU2800051C2 (ru) 2019-03-14 Способ лечения и/или профилактики астмы, обострения астмы, аллергических астматических расстройств и/или расстройств дыхательных путей, связанных с микробиотой
PCT/EP2019/074562 WO2020182322A1 (en) 2019-03-14 2019-09-13 Method of treating and/or preventing asthma, asthma exacerbations, allergic asthma and/or associated conditions with microbiota related to respiratory disorders

Publications (1)

Publication Number Publication Date
MX2021010908A true MX2021010908A (es) 2021-10-01

Family

ID=67988987

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021010908A MX2021010908A (es) 2019-03-14 2019-09-13 Metodo para tratar y/o prevenir asma, exacerbaciones de asma, asma alergica y/o condiciones asociadas con microbiota relacionada con trastornos respiratorios.

Country Status (9)

Country Link
US (1) US20220143111A1 (es)
JP (1) JP2022547365A (es)
KR (1) KR20220006039A (es)
CN (1) CN113613665A (es)
AU (1) AU2019434478A1 (es)
BR (1) BR112021018086A2 (es)
CA (1) CA3132082A1 (es)
MX (1) MX2021010908A (es)
WO (1) WO2020182322A1 (es)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8007911A (pt) 1979-12-06 1981-06-16 Glaxo Group Ltd Inalador aperfeicoado
DE3274065D1 (de) 1981-07-08 1986-12-11 Draco Ab Powder inhalator
FI88112C (fi) 1985-07-30 1993-04-13 Glaxo Group Ltd Anordning foer administrering av laekemedel till patienter
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
SK280967B6 (sk) 1990-03-02 2000-10-09 Glaxo Group Limited Inhalačný prístroj
WO1992022286A1 (en) 1991-06-12 1992-12-23 Minnesota Mining And Manufacturing Company Albuterol sulfate suspension aerosol formulations
US5337740A (en) 1991-08-01 1994-08-16 New England Pharmaceuticals, Inc. Inhalation devices
US5239993A (en) 1992-08-26 1993-08-31 Glaxo Inc. Dosage inhalator providing optimized compound inhalation trajectory
US5415162A (en) 1994-01-18 1995-05-16 Glaxo Inc. Multi-dose dry powder inhalation device
US7171965B2 (en) 2000-02-01 2007-02-06 Valois S.A.S. Breath actuated dry powder inhaler and tape dose strip
WO2005042017A1 (en) * 2003-10-22 2005-05-12 Id Biomedical Corporation Of Quebec Compositions and methods for activating innate and allergic immunity
EP1928484B1 (en) 2005-08-26 2010-02-24 The Board Of Trustees Of The Leland Stanford Junior University Methods for treatment of headaches by administration of oxytocin
EP3332791A1 (en) 2007-03-05 2018-06-13 OM Pharma Bacterial extract for respiratory disorders and process for its preparation
US8889622B2 (en) 2007-07-25 2014-11-18 Washington University Methods of inhibiting seizure in a subject
US7745670B2 (en) 2008-06-27 2010-06-29 Codman & Shurtleff, Inc. Curcumin-Resveratrol hybrid molecule
EP2326339A4 (en) 2008-05-21 2012-06-20 Neurotez Inc METHOD FOR TREATING PROGRESSIVE COGNITIVE DISORDER IN CONNECTION WITH NEUROFIBRILLARY TANGLES
CA2765448A1 (en) * 2009-06-15 2010-12-23 Universite Laval Stimulation of innate immunity with an antigen from bacterial origin
KR20200044990A (ko) * 2011-03-21 2020-04-29 알티뮨 인크. 급속 및 지속적 면역학적제제-치료제
EP3937957A1 (en) * 2019-03-14 2022-01-19 OM Pharma SA Process for making stable bacterial extracts and their use as pharmaceuticals

Also Published As

Publication number Publication date
AU2019434478A1 (en) 2021-09-23
KR20220006039A (ko) 2022-01-14
BR112021018086A2 (pt) 2021-11-23
WO2020182322A1 (en) 2020-09-17
US20220143111A1 (en) 2022-05-12
JP2022547365A (ja) 2022-11-14
CN113613665A (zh) 2021-11-05
CA3132082A1 (en) 2020-09-17

Similar Documents

Publication Publication Date Title
MX2020002652A (es) Esteroides neuroactivos y su método de uso.
MX2020009856A (es) Rimegepant para trastornos relacionados con el peptido relacionado con el gen para calcitonina (cgrp).
MX2016011132A (es) Métodos para tratar una infección cutánea mediante la administración de un antagonista de il-4r.
HRP20200661T1 (hr) Razine ceramida u liječenju i prevenciji infekcija
MX2015012397A (es) Composiciones y metodos basados en anticuerpos neutralizados suministrados intranasalmente para eficacia terapeutica aumentada.
CA2897464C (en) Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide
MX2018012719A (es) Ram negativas para tratar la dermatitis atopica.
MX2019006848A (es) Metodos para tratar condiciones inflamatorias de los pulmones.
MY158522A (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory diseases or condition
WO2016036232A3 (en) Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system
PH12019500622A1 (en) Ammonia oxidixing microorganisms for use and delivery to the intranasal system
WO2016161055A3 (en) Methods of treating cancers, autoimmune disorders, and other conditions associated with chronic inflammation
MX2019009586A (es) Composiciones y metodos para tratar enfermedades asociadas con la permeabilidad del epitelio intestinal.
MX2020007971A (es) Composiciones y metodos para tratar edema pulmonar o inflamacion pulmonar.
MX2022015965A (es) Combinacion de alcaftadina y un corticoesteroide.
MX2020013115A (es) Compuestos de tetrahidrobenzofuro[2,3-c]piridina y beta-carbolina para el tratamiento, el alivio o la prevencion de trastornos asociados con los agregados de tau.
MY189342A (en) Treatment and prevention of the common cold using povidone-iodine
MX2021011958A (es) Terapias genicas para trastornos lisosomales.
EP3937937A4 (en) TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH MITOCHONDRIA, INCLUDING THEIR SYMPTOMS USING PRIDOPIDINE
MX2019002047A (es) Metodos y composiciones para tratar infecciones fungicas cutaneas.
MX2021010908A (es) Metodo para tratar y/o prevenir asma, exacerbaciones de asma, asma alergica y/o condiciones asociadas con microbiota relacionada con trastornos respiratorios.
MX2021015012A (es) Inhalable que comprende ciclodextrina para su uso en el tratamiento de inflamaciones nasales.
WO2015100448A3 (en) Multimodal antimicrobial therapy
PH12021550671A1 (en) Prodrugs of cgrp antagonists
MX2023005591A (es) Metodos de tratamiento de enfermedades y trastornos.